Safety of Intravenous Thrombolysis within 4.5 h of Symptom Onset in Patients with Negative Post-Treatment Stroke Imaging for Cerebral Infarction
- 11 March 2011
- journal article
- Published by Springer Science and Business Media LLC in Neurocritical Care
- Vol. 15 (1), 76-79
- https://doi.org/10.1007/s12028-011-9523-x
Abstract
Patients with stroke symptoms but negative diffusion-weighted imaging (DWI) might have transient ischemic attacks (TIA) or stroke mimics. Brain DWI is important for the diagnosis of cerebral infarction but it is not available before thrombolysis for most patients to avoid treatment delay. This study aimed to evaluate the safety of IV thrombolysis in patients with a negative post-treatment DWI for cerebral infarction. We conducted a retrospective study of 89 patients treated with IV recombinant tissue plasminogen activator (rt-PA) within 4.5 h after stroke symptom onset. The patients were identified in our acute stroke registry from January 2009 to September 2010. Information on patients’ demographics, clinical characteristics, neuroimaging, treatment complications, and outcomes was obtained and analyzed. Out of 89 patients, 23 patients (26%) had a negative DWI on follow-up stroke imaging. Fourteen patients had a TIA and nine patients had a stroke mimic, including Todd’s paralysis, complicated migraine, and somatoform disorder. We found significant differences between patients with a positive and a negative DWI in mean age (62 years vs. 52 years; P < 0.01) and median admission NIH stroke scale score (11 points versus 6 points; P < 0.001). Among patients with a positive DWI, four patients had a symptomatic intracerebral hemorrhage (ICH). No patients with a negative DWI had symptomatic or asymptomatic ICH. Our results suggest that the administration of IV rt-PA within the first 4.5 h of symptom onset in patients with suspected ischemic stroke is safe even when post-treatment DWI does not demonstrate cerebral infarction.Keywords
This publication has 13 references indexed in Scilit:
- Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke [RETIRED]Neurology, 2010
- Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemiaNeurology, 2010
- Transient Ischemic Attack after Tissue Plasminogen Activator: Aborted Stroke or Unnecessary Stroke Therapy?Cerebrovascular Diseases, 2009
- Thrombolysis in Stroke MimicsStroke, 2009
- The Incidence of Stroke Mimics Among Stroke Department Admissions in Relation to Age GroupJournal Of Stroke & Cerebrovascular Diseases, 2008
- Identification of Nonischemic Stroke Mimics Among 411 Code Strokes at the University of California, San Diego, Stroke CenterJournal Of Stroke & Cerebrovascular Diseases, 2008
- Distinguishing Between Stroke and Mimic at the BedsideStroke, 2006
- Misdiagnosis of stroke in tissue plasminogen activator–treated patients: Characteristics and outcomesAnnals of Emergency Medicine, 2003
- Stroke mimics and chameleonsEmergency Medicine Clinics of North America, 2002
- Should Thrombolytic Therapy Be the First-Line Treatment for Acute Ischemic Stroke?New England Journal of Medicine, 1997